N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells

Cancer Research

Volumn 58, Issue 1, 1998, Pages 135-141

  Aquilina, Gabriele ^a   Ceccotti, Sabrina ^a   Martinelli, Simone ^a   Hampson, Richard ^b   Bignami, Margherita ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; METHYLNITROSOUREA;

ANIMAL CELL; ARTICLE; BASE MISPAIRING; CELL SURVIVAL; CHO CELL; CONTROLLED STUDY; DNA CROSS LINKING; DNA METHYLATION; DNA REPAIR; DRUG CYTOTOXICITY; DRUG SENSITIVITY; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAJI CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CHO CELLS; CRICETINAE; DNA REPAIR; GUANINE; HELA CELLS; HUMANS; LOMUSTINE; METHYLATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 0031975303     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Kastan, M., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
2. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
3. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
4. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
5. Fan, S., El-Deiry, W. S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J., Magrath, I., Kohn, K. W., and O'Connor, P. M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA-damaging agents. Cancer Res., 54: 5824-5830, 1994.
6. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D., Housman, D. E., and Jack, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
7. Lowe, S. W. Cancer therapy and p53. Curr. Opin. Oncol., 7: 547-553, 1995.
8. 6-methylguanine-DNA alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol., 51: 167-223, 1995.
9. 6-methylguanine-DNA methyltransferase. Nucleic Acids Res., 11: 7743-7757, 1983.
10. Brent, T. P. Suppression of cross-link formation in chloroethylnitrosourea-treated DNA by an activity in extracts of human leukemic lymphoblasts. Cancer Res., 44: 1887-1892, 1984.
11. 3-deoxycytidyl)-2-N′-deoxyguanosyl)-ethane, in DNA treated with N,N-bis(2-chloroethyl)-N-nitrosourea (BCNU). Cancer Res., 42: 3102-3105, 1982.
12. Erickson, L. C., Laurent, G., Sharkey, N. A., and Kohn, K. W. DNA cross-linking and monoadduct repair in nitrosourea-treated human cells. Nature (Lond.), 288: 727-729, 1980.
13. 6-alkylguanine DNA-alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methyl cyclohexyl)-1-nitrosourea. Proc. Natl. Acad. Sci. USA, 82: 2985-2989, 1985.
14. Habraken, Y., Carter, C. A., Kirk, M. C., and Ludlum, D. B. Release of 7-alkylguanines from N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea-modified DNA by 3-methyladenine DNA glycosylase II. Cancer Res., 51: 499-503, 1991.
15. Matijasevic, Z., Boosalis, M., Mackay, W., Samson, L., and Ludlum, D. B. Protection against chloroethylnitrosourea cytotoxicity by eukaryotic 3-methyladenine DNA glycosylase. Proc. Natl. Acad. Sci. USA, 90: 11855-11859, 1993.
16. Engelward, B. P., Dreslin, A., Christensen, J., Huszar, D., Kurahara, C., and Samson, L. Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J., 15: 945-952, 1996.
17. Karran, P., and Bignami, M. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res., 20: 2933-2940, 1992.
18. Karran, P., and Bignami, M. DNA damage tolerance, mismatch repair and genome instability. BioEssays, 16: 833-839, 1994.
19. Branch, P., Aquilina, G., Bignami, M., and Karran, P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature (Lond.), 362: 652-654, 1993.
20. Kat, A., Thilly, W. G., Fang, W-H., Longley, M. J., Li, G-M., and Modrich, P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA, 90: 6424-6428, 1993.
21. O'Regan, N. E.,. Branch, P., MacPherson, P., and Karran, P. hMSH2-independent DNA mismatch recognition by human proteins. J. Biol. Chem., 271: 1789-1796, 1995.
22. 6-methylguanine by mismatch correction in human cell extracts. Curr. Biol., 6: 1528-1531, 1996.
23. Branch, P., Hampson, R., and Karran, P. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res., 55: 2304-2309, 1995.
24. Koi, M., Umar, A., Chauhan, D., Cherian, S. P., Carethers, J. M., Kunkel, T. A., and Boland, C. R. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res., 54: 4308-4312, 1994.
25. Risinger, J. I., Umar, A., Barrett, J. C., and Kunkel, T. A. A hPMS2 mutant cell line is defective in strand-specific mismatch repair. J. Biol. Chem., 270: 18183-18186, 1995.
26. Liu, L., Markowitz, S., and Gerson, S. L. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res., 56: 5375-5379, 1996.
27. 6-benzylguanine: a comparative study in vitro. Br. J. Cancer, 73: 482-490, 1996.
28. 6-methylguanine-DNA alkyltransferase. Br. J. Cancer, 74: 1030-1036, 1996.
29. - derivatives of an SV40-immortalized human fibroblast cell line. Carcinogenesis (Lond.), 10: 893-898, 1989.
30. Kaina, B., Van Zeeland, A. A., Backendorf, C., Thielmann, H. W., and Van de Putte, P. Transfer of human genes conferring resistance to methylating mutagens but not to UV irradiation and cross-linking agents into Chinese hamster ovary cells. Mol. Cell. Biol., 7: 2024-2030, 1987.
31. 6-methylguanine and 6-thioguanine cytotoxic effects: a cross-resistant phenotype in N-methylnitrosourea-resistant Chinese hamster ovary cells. Cancer Res., 50: 4248-4253, 1990.
32. Aquilina, G., Hess, P., Fiumicino, S., Ceccotti, S., and Bignami, M. A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damage. Cancer Res., 55, 2569-2575, 1995.
33. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51: 3367-3372, 1991.
34. 6-methylguanine-DNA methyltransferase expression in acquired resistance to methylating agents in human cells. J. Biol. Chem., 272: 28596-28606, 1997.
35. 6-methylguanine-DNA methyltransferase-proficient CHO cells. Carcinogenesis (Lond.), 9: 1217-1222, 1988.
36. Aquilina, G., Hess, P., Branch, P., Macgeoch, C., Casciano, I., Karran, P., and Bignami, M. A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype. Proc. Natl. Acad. Sci. USA, 91: 8905-8909, 1994.
37. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 5368-5372, 1990.
38. 6-alkylguanine-DNA alkyltransferase. Cancer Res., 48: 1521-1527, 1988.
39. 6-methylguanine induces intrachromosomal homologous recombination in human cells. Carcinogenesis (Lond.), 17: 2229-2235, 1996.
40. Ali-Osman, F. Attenuation of DNA interstrand cross-linking by glutathione. Cancer Res., 49: 5258-5261, 1989.
41. Smith, T., Evans, C. G., Doane-Setzer, P., Castro, V. M., Tahir, M. K., and Mannervik, B. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class μ glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res., 49: 2621-2625, 1989.
42. Nutt, C. L., Chambers, A. F., and Cairncross, J. G. Wild-type p53 renders mouse astrocytes resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea despite the absence of a p53-dependent cell cycle arrest. Cancer Res., 56: 2748-2751, 1996.
43. Duthu, A., Debuire, B., Romano, J., Ehrhart, J. C., Fiscella, M., May, E., Appella, E., and May, P. p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas. Oncogene, 7: 2161-2167, 1992.
44. Lee, H., Larner, J. M., and Hamlin, J. L. Cloning and characterization of Chinese hamster p53 cDNA. Gene (Amst.), 184: 177-183, 1997.
45. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
46. Souza, R. F., Appel, R., Yin, J., Wang, S., Smolinski, K. N., Abraham, J. M., Zou, T-T., Shi, Y-Q., Lei, J., Cottrell, J., Cymes, K., Biden, K., Simms, L., Leggett, B., Lynch, P. M., Frazier, M., Powell, S. M., Harpaz, N., Sugimura, H., Young, J., and Meltzer, S. J. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat. Genet., 14: 255-257, 1996.
47. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., and Perucho, M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science (Washington DC), 275: 967-969, 1997.
48. Broggini, M., Erba, E., Morasca, L., Horgan, C., and D' Incalci, M. In vivo studies of a novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma. Cancer Chemother. Pharmacol., 16: 125-128, 1986.
49. Catapano, C. V., Broggini, M., Erba, E., Ponti, M., Mariani, L., Citti, L., and D'Incalci, M. In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas. Cancer Res., 47: 4884-4889, 1987.
50. Ludlum, D. B. DNA alkylation by haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. Mutat. Res., 233: 117-126, 1990.
51. Cappelli, E., Redaelli, A., Rivano, M. E., Abbondandolo, A., and Frosina, G. Repair of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea-induced damage by mammalian cell extracts. Carcinogenesis (Lond.), 16: 2267-2270, 1995.
52. Stefanini, M., Mondello, C., Tessear, L., Capuano, V., Guerra, B. R., and Nuzzo, F. Sensitivity to DNA-damaging agents and mutation by UV light in UV-sensitive CHO cells. Mutat. Res., 174: 155-159, 1986.
53. 6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents. Cancer Res., 52: 32-35, 1992.
54. Wood, R. D. DNA repair in eukaryotes. Annu. Rev. Biochem., 65: 135-167, 1996.
55. de Wind, N., Dekker, M., Berns, A., Radman, M., and te Riele, H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination and predisposition to cancer. Cell, 82: 321-330, 1995.
56. Rodrigues, N. R., Rowan, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
57. Anthoney, D. A., Mcllwrath, A. I., Gallagher, W. M., Edlin, A. R. M., and Brown, R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res., 56: 1374-1381, 1996.
58. Malkhosyan, S., Rampino, N., Yamamoto, H., and Perucho, M. Frameshift mutator mutations. Nature (Lond.), 382: 499-500, 1996.
59. Carroll, A. G., Voeller, H. J., Sugars, L., and Gelman, E. P. p53 oncogene mutations in three human prostate cancer cell lines. Prostate, 23: 123-134, 1993.
60. Yaginuma, Y., and Westphal, H. Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res., 51: 6506-6509, 1991.
61. Albright, C. D., Tsongalis, G. J., Resau, I. H., and Kaufman, D. G. Human endometrial carcinoma cells release factors which inhibit the growth of normal epithelial cells in culture. Cell Biol. Toxicol., 11: 251-261, 1995.
62. Take, Y., Kumano, M., Teraoka, H., Nishimura, S., and Okuyama, A. DNA-dependent protein kinase inhibitor (OK-1035) suppresses p21 expression in HCT116 cells containing wild-type p53 induced by Adriamycin. Biochem. Biophys. Res. Commun., 221: 207-212, 1996.
63. + tumor cells. Cell, 75: 1227-1236, 1993.
64. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
65. -/- human cancer cells. Cancer Res., 56: 2250-2255, 1996.
66. Umar, A., Boyer, J. C., Thomas, D. C., Nguyen, D. C., Risinger, J. I., Boyd, J., Ionov, J., Perucho, M., and Kunkel, T. A. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J. Biol. Chem., 269: 14367-14370, 1994.
67. 1-S boundary after irradiation. Oncogene, 12: 875-882, 1996.
68. Liu, B., Nicolaides, N. C., Markowitz, S., Willson, J. K. W., Parsons, R. E., Jen, J., Papadopoulos, N., Peltomaki, P., de la Chapelle, A., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat. Genet., 9: 48-55, 1995.
69. da Costa, L. T., Liu, B., El-Deiry, W. S., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Polymerase δ variants in RER colorectal tumours. Nat. Genet., 9: 10-11, 1995.
70. Papadopoulos, N., Nicolaides, N. C., Liu, B., Parsons, R., Lengauer, C., Palombo, F., D'Arrigo, A., Markowitz, S., Willson, J. K. V., Kinzler, K. W., Jiricny, J., and Vogelstein, B. Mutations of GTBP in genetically unstable cells. Science (Washington DC), 268: 1915-1917, 1995.